|Table 3: Distribution of the thrombophilic mutations identified in our study cohort.|
|(*1) are subjects with total APCR (acquired +modified).|
(*2) are subjects with acquired APCR, without inherited FVL.
(*3) are negative APCR subjects tested out of 767.
: Number of subjects; ht: Heterozygotes; hom: Homozygotes; H: Haplotype.
Subjects identified with more than one mutation simultaneously:
in the total APCR group, (inherited plus acquired) They had 13 subjects with MTHFR+FVL; 1subject with MTHFR + FVL + Cambridge; 7 subjects with MTHFR + HR2; 1 subject with prothrombin G20210A + HR2; and 1 subject with prothrombin G20210A + MTHFR; in the acquired APCR group, They had 7 subjects with MTHFR+HR2; 1 subject with prothrombin G20210A + HR2; 1 subject with prothrombin G20210A + MTHFR.